Abiopharma

Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program

10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Geron to Participate in the 2025 Wells Fargo Healthcare Conference

FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

Xencor to Participate at Upcoming Investor Conferences

Personalis to Participate in Upcoming Investor Conferences

Jabra Elite 8 Active Gen 2: Updates and Review (2025)

Mirum Pharma - Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

Bryson Anna 🟡 adjusted position in 40.0K shares (3 derivative) of Doximity, Inc. (DOCS) at $66.76 ($3.0M) Transaction Date: Aug 26, 2025 | Filing ID: 000004

Best Apple Accessories You Can Buy On Amazon

AirPods Pro 3: Everything We Know Ahead of the September 2025 Launch

How to Connect Airpods to iPhone (2025 Guide)